Curiel DT - Search Results

1

Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma.

Zhu ZB, Chen Y, Makhija SK, Lu B, Wang M, Rivera AA, Yamamoto M, Wang S, Siegal GP, Curiel DT, McDonald JM. Zhu ZB, et al. Among authors: curiel dt. Int J Oncol. 2006 Nov;29(5):1319-29. Int J Oncol. 2006. PMID: 17016667

2

Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody.

Deshane J, Cabrera G, Grim JE, Siegal GP, Pike J, Alvarez RD, Curiel DT. Deshane J, et al. Among authors: curiel dt. Gynecol Oncol. 1995 Oct;59(1):8-14. doi: 10.1006/gyno.1995.1260. Gynecol Oncol. 1995. PMID: 7557620

3

Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferative effect in erbB2 overexpressing cancer cell lines.

Deshane J, Loechel F, Conry RM, Siegal GP, King CR, Curiel DT. Deshane J, et al. Among authors: curiel dt. Gene Ther. 1994 Sep;1(5):332-7. Gene Ther. 1994. PMID: 7584099

4

Recombinant adenovirus-mediated gene transfer to genitourinary epithelium in vitro and in vivo.

Bass C, Cabrera G, Elgavish A, Robert B, Siegal GP, Anderson SC, Maneval DC, Curiel DT. Bass C, et al. Among authors: curiel dt. Cancer Gene Ther. 1995 Jun;2(2):97-104. Cancer Gene Ther. 1995. PMID: 7621262

5

Targeted tumor killing via an intracellular antibody against erbB-2.

Deshane J, Siegal GP, Alvarez RD, Wang MH, Feng M, Cabrera G, Liu T, Kay M, Curiel DT. Deshane J, et al. Among authors: curiel dt. J Clin Invest. 1995 Dec;96(6):2980-9. doi: 10.1172/JCI118370. J Clin Invest. 1995. PMID: 8675670 Free PMC article.

6

Intracellular antibody against erbB-2 mediates targeted tumor cell eradication by apoptosis.

Deshane J, Grim J, Loechel S, Siegal GP, Alvarez RD, Curiel DT. Deshane J, et al. Among authors: curiel dt. Cancer Gene Ther. 1996 Mar-Apr;3(2):89-98. Cancer Gene Ther. 1996. PMID: 8729907

7

Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma.

Rosenfeld ME, Wang M, Siegal GP, Alvarez RD, Mikheeva G, Krasnykh V, Curiel DT. Rosenfeld ME, et al. Among authors: curiel dt. J Mol Med (Berl). 1996 Aug;74(8):455-62. doi: 10.1007/BF00217521. J Mol Med (Berl). 1996. PMID: 8872859

8

Gene therapy and ovarian cancer: a review.

Barnes MN, Deshane JS, Rosenfeld M, Siegal GP, Curiel DT, Alvarez RD. Barnes MN, et al. Among authors: curiel dt. Obstet Gynecol. 1997 Jan;89(1):145-55. doi: 10.1016/s0029-7844(96)00296-7. Obstet Gynecol. 1997. PMID: 8990458 Review.

9

Transductional efficacy and safety of an intraperitoneally delivered adenovirus encoding an anti-erbB-2 intracellular single-chain antibody for ovarian cancer gene therapy.

Deshane J, Siegal GP, Wang M, Wright M, Bucy RP, Alvarez RD, Curiel DT. Deshane J, et al. Among authors: curiel dt. Gynecol Oncol. 1997 Mar;64(3):378-85. doi: 10.1006/gyno.1996.4566. Gynecol Oncol. 1997. PMID: 9062138

10

Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor.

Goldman CK, Rogers BE, Douglas JT, Sosnowski BA, Ying W, Siegal GP, Baird A, Campain JA, Curiel DT. Goldman CK, et al. Among authors: curiel dt. Cancer Res. 1997 Apr 15;57(8):1447-51. Cancer Res. 1997. PMID: 9108444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters